메뉴 건너뛰기




Volumn 13, Issue 2, 2013, Pages

Aspirin and clopidogrel for prevention of ischemic stroke topical collection on stroke

Author keywords

Antiplatelet resistance; Aspirin; Aspirin resistance; Clopidogrel; Clopidogrel resistance; CYP2C19 polymorphism; Dipyridamole; Phosphodiasterase inhibitors; Stroke; Thienopyridines; Transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE; HEPARIN; PLACEBO; SULFINPYRAZONE; TICLOPIDINE; WARFARIN; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; FIBRINOLYTIC AGENT;

EID: 84873096970     PISSN: 15284042     EISSN: 15346293     Source Type: Journal    
DOI: 10.1007/s11910-012-0327-y     Document Type: Review
Times cited : (14)

References (80)
  • 1
    • 0001281980 scopus 로고
    • Observations of the fundus oculi in transient monocular blindness
    • 13657292 10.1212/WNL.9.5.333 1:STN:280:DyaG1M%2Fos12muw%3D%3D
    • Fisher CM. Observations of the fundus oculi in transient monocular blindness. Neurology. 1959;9:333-47.
    • (1959) Neurology. , vol.9 , pp. 333-347
    • Fisher, C.M.1
  • 2
    • 72949154065 scopus 로고
    • Use of anticoagulants in patients with progressive cerebral infarction
    • 13691124 10.1212/WNL.11.7.601 1:STN:280:DyaF3c%2FhtVCjsw%3D%3D
    • Carter A. Use of anticoagulants in patients with progressive cerebral infarction. Neurology. 1961;11:601-9.
    • (1961) Neurology. , vol.11 , pp. 601-609
    • Carter, A.1
  • 3
    • 73649170812 scopus 로고
    • Anticoagulant therapy in cerebral infarction: Report on cooperative study
    • Baker RN, Broward HC, Fang HC. Anticoagulant therapy in cerebral infarction: Report on cooperative study. Neurology. 1962;12:823-35.
    • (1962) Neurology , vol.12 , pp. 823-835
    • Baker, R.N.1    Broward, H.C.2    Fang, H.C.3
  • 4
    • 0009322367 scopus 로고
    • Acetylsalicylic acid: Possible preventive of coronary thrombosis
    • 15403207 1:STN:280:DyaG3c%2Fht1yguw%3D%3D
    • Craven LL. Acetylsalicylic acid: possible preventive of coronary thrombosis. Ann West Med Surg. 1950;4:95-9.
    • (1950) Ann West Med Surg , vol.4 , pp. 95-99
    • Craven, L.L.1
  • 5
    • 0014190795 scopus 로고
    • Impaired platelet connective-tissue reaction in man after aspirin ingestion
    • 4166411 10.1016/S0140-6736(67)91658-3 1:STN:280:DyaF2s3gvVyktQ%3D%3D
    • Weiss HJ, Aledort LM. Impaired platelet connective-tissue reaction in man after aspirin ingestion. Lancet. 1967;2:495-7.
    • (1967) Lancet. , vol.2 , pp. 495-497
    • Weiss, H.J.1    Aledort, L.M.2
  • 6
    • 0014184975 scopus 로고
    • Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine
    • 6080853 1:STN:280:DyaF1c7islWnsA%3D%3D
    • Jorgensen L, Rowsell HC, Hovig T, Glynn MF, Mustard JF. Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine. Laboratory Investigation. 1967;17:616-44.
    • (1967) Laboratory Investigation , vol.17 , pp. 616-644
    • Jorgensen, L.1    Rowsell, H.C.2    Hovig, T.3    Glynn, M.F.4    Mustard, J.F.5
  • 8
    • 79960634960 scopus 로고    scopus 로고
    • Historical perspectives and future directions in platelet research
    • 21781274 10.1111/j.1538-7836.2011.04356.x
    • Coller BS. Historical perspectives and future directions in platelet research. J Thromb Haemost. 2011;9 Suppl 1:374-95.
    • (2011) J Thromb Haemost. , vol.9 , Issue.SUPPL. 1 , pp. 374-395
    • Coller, B.S.1
  • 9
    • 0020692577 scopus 로고
    • Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man
    • FitzGerald GA, Oates JA, Hawiger J, Maas RL, Roberts LJD, Lawson JA, et al. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man. J Clin Invest. 1983;71:676-88. (Pubitemid 13160815)
    • (1983) Journal of Clinical Investigation , vol.71 , Issue.3 , pp. 676-688
    • FitzGerald, G.A.1    Oates, J.A.2    Hawiger, J.3
  • 11
    • 0017393590 scopus 로고
    • Controlled trial of aspirin in cerebral ischemia
    • 324036 10.1161/01.STR.8.3.301 1:STN:280:DyaE2s7nsFGhuw%3D%3D
    • Fields WS, Lemak NA, Frankowski RF, Hardy RJ. Controlled trial of aspirin in cerebral ischemia. Stroke. 1977;8:301-16.
    • (1977) Stroke. , vol.8 , pp. 301-316
    • Fields, W.S.1    Lemak, N.A.2    Frankowski, R.F.3    Hardy, R.J.4
  • 12
    • 0018138512 scopus 로고
    • A randomized trial of aspirin and sulfinpyrazone in threatened stroke
    • The Canadian Cooperative Study Group 299
    • The Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med.1978;13;299(2):53-9.
    • (1978) N Engl J Med , vol.13 , Issue.2 , pp. 53-59
  • 13
    • 0020679929 scopus 로고
    • 'AICLA' controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia
    • Bousser MG, Eschwege E, Haguenau M, Lefaucconnier JM, Thibult N, Touboul D, et al. «AICLA» controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Stroke. 1983;14(1):5-14. (Pubitemid 13174990)
    • (1983) Stroke , vol.14 , Issue.1 , pp. 5-14
    • Bousser, M.G.1    Eschwege, E.2    Haguenau, M.3
  • 14
    • 0023472546 scopus 로고
    • Group. The European Stroke Prevention Study (ESPS). Principal end-points
    • The ESPS. Group. The European Stroke Prevention Study (ESPS). Principal end-points. Lancet. 1987;2(8572):1351-4.
    • (1987) Lancet. , vol.2 , Issue.8572 , pp. 1351-1354
  • 15
    • 0025043368 scopus 로고
    • Progress report of the Stroke Prevention in Atrial Fibrillation Study
    • Anderson DC. Progress report of the Stroke Prevention in Atrial Fibrillation Study. Stroke. 1990;21(Suppl 11): III12-7.
    • (1990) Stroke , vol.21 , Issue.SUPPL. 11
    • Anderson, D.C.1
  • 16
    • 0026355123 scopus 로고
    • The United Kingdom transient ischemic attack (UK-TIA) aspirin trial: Final results
    • 1783914 10.1136/jnnp.54.12.1044 1:STN:280:DyaK387kvVClsA%3D%3D
    • Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991;54(12):1044-54.
    • (1991) J Neurol Neurosurg Psychiatry. , vol.54 , Issue.12 , pp. 1044-1054
    • Farrell, B.1    Godwin, J.2    Richards, S.3    Warlow, C.4
  • 17
    • 0026072561 scopus 로고
    • A comparison of 2 doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke
    • The Dutch TIA Trial Study Group The Dutch TIA Trial Study Group
    • The Dutch TIA Trial Study Group. A comparison of 2 doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischemic attack or minor ischemic stroke. The Dutch TIA Trial Study Group. N Engl J Med. 1991;325(18):1261-6.
    • (1991) N Engl J Med , vol.325 , Issue.18 , pp. 1261-1266
  • 18
    • 0027942293 scopus 로고
    • Antiplatelet therapy for thromboprophylaxis: The need for careful consideration of the evidence from randomized trials. Antiplatelet Trialists' Collaboration
    • 7987156 10.1136/bmj.309.6963.1215 1:STN:280:DyaK2M%2FnvVKltg%3D%3D
    • Collins R, Baigent C, Sandercock P, Peto R. Antiplatelet therapy for thromboprophylaxis: the need for careful consideration of the evidence from randomized trials. Antiplatelet Trialists' Collaboration. BMJ. 1994;309(6963):1215-7.
    • (1994) BMJ , vol.309 , Issue.6963 , pp. 1215-1217
    • Collins, R.1    Baigent, C.2    Sandercock, P.3    Peto, R.4
  • 19
    • 0030297319 scopus 로고    scopus 로고
    • European stroke prevention study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke
    • DOI 10.1016/S0022-510X(96)00308-5, PII S0022510X96003085
    • Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996;143(1-2):1-13. (Pubitemid 26402780)
    • (1996) Journal of the Neurological Sciences , vol.143 , Issue.1-2 , pp. 1-13
    • Diener, H.C.1    Cunha, L.2    Forbes, C.3    Sivenius, J.4    Smets, P.5    Lowenthal, A.6
  • 20
    • 84873091987 scopus 로고    scopus 로고
    • Randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke
    • CAST Collaborative Group. CAST (Chinese Acute Stroke Trial)
    • CAST Collaborative Group. CAST (Chinese Acute Stroke Trial). Randomized placebo-controlled trial of early aspirin use in 20,000 patients with acute ischemic stroke. Lancet. 1997;349(9066):1649.
    • (1997) Lancet. , vol.349 , Issue.9066 , pp. 1649
  • 21
    • 0030911057 scopus 로고    scopus 로고
    • The International Stroke Trial (IST): A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
    • DOI 10.1016/S0140-6736(97)04011-7
    • International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomized trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischemic stroke. Lancet. 1997;349(9065):1569-81. (Pubitemid 27229136)
    • (1997) Lancet , vol.349 , Issue.9065 , pp. 1569-1581
    • Sandercock, P.A.G.1
  • 22
    • 0031455701 scopus 로고    scopus 로고
    • A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin
    • DOI 10.1002/ana.410420606
    • The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. A randomized trial of anticoagulants vs aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol. 1997;42(6):857-65. (Pubitemid 28008415)
    • (1997) Annals of Neurology , vol.42 , Issue.6 , pp. 857-865
    • Algra1
  • 23
    • 0034621003 scopus 로고    scopus 로고
    • Low molecular-weight heparin versus aspirin in patients with acute ischaemic stroke and atrial fibrillation: A double-blind randomised study
    • Berge E, Abdelnoor M, Nakstad PH, Sandset PM. Low molecular-weight heparin vs aspirin in patients with acute ischemic stroke and atrial fibrillation: a double-blind randomized study. Lancet. 2000;355(9211):1205-10. (Pubitemid 30184528)
    • (2000) Lancet , vol.355 , Issue.9211 , pp. 1205-1210
    • Berge, E.1    Abdelnoor, M.2    Nakstad, P.H.3    Sandset, P.M.4
  • 24
    • 0036278194 scopus 로고    scopus 로고
    • Warfarin-Aspirin Recurrent Stroke Study (WARSS) trial: Is warfarin really a reasonable therapeutic alternative to aspirin for preventing recurrent noncardioembolic ischemic stroke?
    • DOI 10.1161/01.STR.0000016922.22707.27
    • Hankey GJ. Warfarin-Aspirin Recurrent Stroke Study (WARSS) Trial: is Warfarin really a reasonable therapeutic alternative to Aspirin for preventing recurrent noncardioembolic ischemic stroke? Stroke. 2002;33:1723-6. (Pubitemid 34619986)
    • (2002) Stroke , vol.33 , Issue.6 , pp. 1723-1726
    • Hankey, G.J.1    Fisher, M.2
  • 25
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Antithrombotic Trialists' Collaboration
    • Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71.
    • (2002) BMJ , vol.324 , pp. 71
  • 26
    • 27144534482 scopus 로고    scopus 로고
    • Recent advances in endoluminal revascularization for intracranial atherosclerotic disease
    • DOI 10.1179/016164105X35486
    • Sauvageau E, Ecker RD, Levy EI, Hanel RA, Guterman LR, Hopkins LN. Recent advances in endoluminal revascularization for intracranial atherosclerotic disease. Neurol Res. 2005;27(Suppl 1):S89-94. (WASID) (Pubitemid 41510937)
    • (2005) Neurological Research , vol.27 , Issue.SUPPL. 1
    • Sauvageau, E.1    Ecker, R.D.2    Levy, E.I.3    Hanel, R.A.4    Guterman, L.R.5    Hopkins, L.N.6
  • 28
    • 65849268320 scopus 로고    scopus 로고
    • Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomized trials
    • IST 1991Antithrombotic Trialists' (ATT) Collaboration
    • IST 1991Antithrombotic Trialists' (ATT) Collaboration. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomized trials. Lancet. 2009;373:1849-60.
    • (2009) Lancet , vol.373 , pp. 1849-1860
  • 29
    • 84861037910 scopus 로고    scopus 로고
    • WARCEF Investigators. Warfarin and aspirin in patients with heart failure and sinus rhythm
    • This study found patients with reduced LVEF but sinus rhythm have a reduced risk of ischemic stroke when treated with warfarin, however this benefit is offset by the increased risk of hemorrhage. This prompts the need for individualization of the choice between aspirin or warfarin
    • •• Homma S, Thompson JL, Pullicino PM, Levin B, Freudenberger RS, Teerlink JR, et al. WARCEF Investigators. Warfarin and aspirin in patients with heart failure and sinus rhythm. N Engl J Med. 2012;366(20):1859-69. This study found patients with reduced LVEF but sinus rhythm have a reduced risk of ischemic stroke when treated with warfarin, however this benefit is offset by the increased risk of hemorrhage. This prompts the need for individualization of the choice between aspirin or warfarin.
    • (2012) N Engl J Med , vol.366 , Issue.20 , pp. 1859-1869
    • Homma, S.1    Thompson, J.L.2    Pullicino, P.M.3    Levin, B.4    Freudenberger, R.S.5    Teerlink, J.R.6
  • 31
    • 0017741743 scopus 로고
    • Prevention of arterial thromboembolism with acetylsalicylic acid. A controlled clinical study in patients with aortic ball valves
    • Dale J, Myhre E, Storstein O, Stormorken H, Efskind L. Prevention of arterial thromboembolism with acetylsalicylic acid: a controlled clinical study in patients with aortic ball valves. Am Heart J. 1977;95(1):101-11. (Pubitemid 8245823)
    • (1977) American Heart Journal , vol.94 , Issue.1 , pp. 101-111
    • Dale, J.1    Myhre, E.2    Storstein, O.3
  • 32
    • 77956899158 scopus 로고    scopus 로고
    • Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
    • This study found warfarin combined with aspirin and/or clopidogrel has a 3-fold higher risk when compared to warfarin monotherapy
    • • Hansen ML, Sørensen R, Clausen MT, Fog-Petersen ML, Raunsø J, Gadsbøll N, et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Arch Intern Med. 2010;170:1433-41. This study found warfarin combined with aspirin and/or clopidogrel has a 3-fold higher risk when compared to warfarin monotherapy.
    • (2010) Arch Intern Med , vol.170 , pp. 1433-1441
    • Hansen Ml, S.1
  • 34
    • 0024406369 scopus 로고
    • Final report on the aspirin component of the ongoing Physicians' Health Study
    • Steering Committee of the Physicians' Health Study Research Group
    • Steering Committee of the Physicians' Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study. N Engl J Med.1989;321:129-35.
    • (1989) N Engl J Med , vol.321 , pp. 129-135
  • 35
    • 84865457524 scopus 로고    scopus 로고
    • The aspirin controversy in primary prevention
    • This study found the risks of primary prevention with aspirin for individuals at low risk for cardiovascular disease may outweigh the benefits as aspirin reduces the risk of MI, but at the cost of an increase in major bleeding with a nominally significant reduction in total mortality
    • •• Raju NC, Eikelboom JW. The aspirin controversy in primary prevention. Current Opin Cardiol. 2012;27(5):499-507. This study found the risks of primary prevention with aspirin for individuals at low risk for cardiovascular disease may outweigh the benefits as aspirin reduces the risk of MI, but at the cost of an increase in major bleeding with a nominally significant reduction in total mortality.
    • (2012) Current Opin Cardiol , vol.27 , Issue.5 , pp. 499-507
    • Raju, N.C.1    Eikelboom, J.W.2
  • 36
    • 84863726621 scopus 로고    scopus 로고
    • Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: A cost-effectiveness analysis
    • This study is significant because it demonstrated the addition of low dose aspirin is efficacious in preventing proximal colorectal cancer, indicating that the use of aspirin may have benefits beyond that of primary prevention of cardiovascular disease
    • • Hassan C, Rex DK, Cooper GS, Zullo A, Launois R, Benamouzig R. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis. Gut. 2012;61 (8):1172-9. This study is significant because it demonstrated the addition of low dose aspirin is efficacious in preventing proximal colorectal cancer, indicating that the use of aspirin may have benefits beyond that of primary prevention of cardiovascular disease.
    • (2012) Gut , vol.61 , Issue.8 , pp. 1172-1179
    • Hassan, C.1    Rex, D.K.2    Cooper, G.S.3    Zullo, A.4    Launois, R.5    Benamouzig, R.6
  • 37
    • 84861884607 scopus 로고    scopus 로고
    • Hemorrhagic complications associated with aspirin: An underestimated hazard in clinical practice?
    • 22706838 10.1001/jama.2012.6152 1:CAS:528:DC%2BC38Xosl2gu74%3D
    • Siller-Matula JM. Hemorrhagic complications associated with aspirin: an underestimated hazard in clinical practice? JAMA. 2012;307(21):2318-20.
    • (2012) JAMA. , vol.307 , Issue.21 , pp. 2318-2320
    • Siller-Matula, J.M.1
  • 38
    • 33746448278 scopus 로고    scopus 로고
    • Systematic Review and Meta-analysis of Adverse Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled Trials
    • DOI 10.1016/j.amjmed.2005.10.039, PII S0002934305010430
    • McQuaid KR, Laine L. Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials. Am J Med. 2006;119(8):624-38. (Pubitemid 44128438)
    • (2006) American Journal of Medicine , vol.119 , Issue.8 , pp. 624-638
    • McQuaid, K.R.1    Laine, L.2
  • 39
    • 84865030062 scopus 로고    scopus 로고
    • Aspirin- and Clopidogrel-associated bleeding complications: Data mining of the public version of the FDA Adverse Event Reporting System, AERS
    • 22859904 10.7150/ijms.4549 1:CAS:528:DC%2BC38XhtFCqsb3F
    • Tamura T, Sakaeda T, Kadoyama K, Okuno Y. Aspirin- and Clopidogrel-associated bleeding complications: data mining of the public version of the FDA Adverse Event Reporting System, AERS. Int J Med Sci. 2012;9(6):441-6.
    • (2012) Int J Med Sci. , vol.9 , Issue.6 , pp. 441-446
    • Tamura, T.1    Sakaeda, T.2    Kadoyama, K.3    Okuno, Y.4
  • 41
    • 0024840409 scopus 로고
    • The 'trials' of a long-term clinical trial: The Ticlopidine Aspirin Stroke Study and the Canadian-American Ticlopidine Study
    • Goyan JE. The «trials» of a long-term clinical trial: the Ticlopidine Aspirin Stroke Study and the Canadian-American Ticlopidine Study. Control Clin Trials. 1989;10 Suppl 4:236S-44S. (Pubitemid 20029390)
    • (1989) Controlled Clinical Trials , vol.10 , Issue.4 SUPPL.
    • Goyan, J.E.1
  • 42
    • 0030590746 scopus 로고    scopus 로고
    • A randomized, blinded, trial of clopidogrel vs aspirin in patients at risk of ischemic events (CAPRIE)
    • CAPRIE steering Committee
    • CAPRIE steering Committee. A randomized, blinded, trial of clopidogrel vs aspirin in patients at risk of ischemic events (CAPRIE). Lancet. 1996;348:1329-39.
    • (1996) Lancet , vol.348 , pp. 1329-1339
  • 43
    • 3242770664 scopus 로고    scopus 로고
    • Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): Randomised, double-blind, placebo-controlled trial
    • DOI 10.1016/S0140-6736(04)16721-4, PII S0140673604167214
    • Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, et al. (MATCH investigators). Aspirin and clopidogrel compared with clopidogrel alone after recent ischemic stroke or transient ischemic attack in high risk patients (MATCH): randomized, double-blind, placebo-controlled trial. Lancet. 2004;364(9431):331-7. (Pubitemid 38970009)
    • (2004) Lancet , vol.364 , Issue.9431 , pp. 331-337
    • Diener, P.H.-C.1    Bogousslavsky, P.J.2    Brass, P.L.M.3    Cimminiello, P.C.4    Csiba, P.L.5    Kaste, P.M.6    Leys, P.D.7    Matias-Guiu, P.J.8    Rupprecht, P.H.-J.9
  • 44
    • 33645861080 scopus 로고    scopus 로고
    • Clopidogrel and aspirin vs aspirin alone for the prevention of atherothrombotic events
    • for the CHARISMA Investigators et al. 16531616 10.1056/NEJMoa060989 1:CAS:528:DC%2BD28Xjs12gsLk%3D
    • Bhatt DL, Fox KA, Hacke W, for the CHARISMA Investigators, et al. Clopidogrel and aspirin vs aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706-17.
    • (2006) N Engl J Med. , vol.354 , pp. 1706-1717
    • Bhatt, D.L.1    Fox, K.A.2    Hacke, W.3
  • 45
    • 35248821708 scopus 로고    scopus 로고
    • Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): A randomised controlled pilot trial
    • DOI 10.1016/S1474-4422(07)70250-8, PII S1474442207702508
    • Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM, FASTER Investigators. Fast assessment of stroke and transient ischemic attack to prevent early recurrence (FASTER): a randomized controlled pilot trial. Lancet Neurol. 2007;6:961-9. (Pubitemid 47562312)
    • (2007) Lancet Neurology , vol.6 , Issue.11 , pp. 961-969
    • Kennedy, J.1    Hill, M.D.2    Ryckborst, K.J.3    Eliasziw, M.4    Demchuk, A.M.5    Buchan, A.M.6
  • 46
    • 51449116270 scopus 로고    scopus 로고
    • Aspirin and extended-release dipyridamole vs clopidogrel for recurrent stroke
    • 18753638 10.1056/NEJMoa0805002 1:CAS:528:DC%2BD1cXhtFGjurjF
    • Sacco RL, Diener HC, Yusuf S, Cotton D, Ounpuu S, Lawton WA, et al. Aspirin and extended-release dipyridamole vs clopidogrel for recurrent stroke. N Engl J Med. 2008;359(12):1238-51.
    • (2008) N Engl J Med. , vol.359 , Issue.12 , pp. 1238-1251
    • Sacco, R.L.1    Diener, H.C.2    Yusuf, S.3    Cotton, D.4    Ounpuu, S.5    Lawton, W.A.6
  • 47
    • 65649145705 scopus 로고    scopus 로고
    • Effect of Clopidogrel added to aspirin in patients with atrial fibrillation
    • The ACTIVE Investigators 10.1056/NEJMoa0901301
    • The ACTIVE Investigators. Effect of Clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009;360:2066-207.
    • (2009) N Engl J Med. , vol.360 , pp. 2066-2207
  • 48
    • 84865485153 scopus 로고    scopus 로고
    • Effects of clopidogrel added to aspirin in patients with recent lacunar stroke
    • The SPS3 Investigators
    • The SPS3 Investigators. Effects of clopidogrel added to aspirin in patients with recent lacunar stroke. N Engl J Med. 2012;367:817-25.
    • (2012) N Engl J Med , vol.367 , pp. 817-825
  • 49
    • 84856159490 scopus 로고    scopus 로고
    • Antiplatelet therapy and managing ulcer risk
    • 22142030 10.1111/j.1440-1746.2011.07029.x 1:CAS:528:DC%2BC38XjtlKnsrg%3D
    • Chan F. Antiplatelet therapy and managing ulcer risk. J Gastroenterol Hepatol. 2012;27(2):195-9.
    • (2012) J Gastroenterol Hepatol. , vol.27 , Issue.2 , pp. 195-199
    • Chan, F.1
  • 50
    • 0034515652 scopus 로고    scopus 로고
    • Prevention and treatment of Thromboembolic and Ischemic complications associated with endovascular procedures : Part I - Pathophysiological and pharmacological features
    • Qureshi AL, Luft AR, Sharma M, Guterman LR, Hopkins LN. Prevention and treatment of thromboembolic and ischemic complications associated with endovascular procedures: Part I-pathophysiological and pharmacological features. Neurosurgery. 2000;46(6):1344-59. (Pubitemid 32037667)
    • (2000) Neurosurgery , vol.46 , Issue.6 , pp. 1344-1359
    • Qureshi, A.I.1    Luft, A.R.2    Sharma, M.3    Guterman, L.R.4    Hopkins, L.N.5
  • 51
    • 33646596912 scopus 로고    scopus 로고
    • Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): Randomised controlled trial
    • DOI 10.1016/S0140-6736(06)68734-5, PII S0140673606687345
    • Halkes PH, van Gijn J, Kappelle LJ, Koudstssl PJ, Algra A, ESPRIT Study Group. Aspirin plus dipyridamole vs aspirin alone after cerebral ischemia of arterial origin (ESPRIT): randomized controlled trial. Lancet. 2006;367:1665-73. (Pubitemid 43728258)
    • (2006) Lancet , vol.367 , Issue.9523 , pp. 1665-1673
  • 54
    • 84873086987 scopus 로고    scopus 로고
    • POINT TRIAL Accessed 1 Oct 2012
    • POINT TRIAL Available at: http://www.pointtrial.org/. Accessed 1 Oct 2012.
  • 55
    • 18244404294 scopus 로고    scopus 로고
    • Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: The clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial
    • DOI 10.1161/01.CIR.0000163561.90680.1C
    • Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, et al. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection: the clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial. Circulation. 2005;111(17):22333-40. (Pubitemid 40632440)
    • (2005) Circulation , vol.111 , Issue.17 , pp. 2233-2240
    • Markus, H.S.1    Droste, D.W.2    Kaps, M.3    Larrue, V.4    Lees, K.R.5    Siebler, M.6    Ringelstein, E.B.7
  • 57
    • 80052834654 scopus 로고    scopus 로고
    • Stenting vs aggressive medical therapy for intracranial arterial stenosis
    • SAMMPRIS Trial Investigators This study found aggressive medical management including dual antiplatelet therapy was superior to percutaneous transluminal angioplasty and stenting (PTAS) with use of the Wingspan stent system due to the increased risk of early stroke aNer PTAS
    • •• Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. SAMMPRIS Trial Investigators. Stenting vs aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365(11):993-1003. This study found aggressive medical management including dual antiplatelet therapy was superior to percutaneous transluminal angioplasty and stenting (PTAS) with use of the Wingspan stent system due to the increased risk of early stroke aNer PTAS.
    • (2011) N Engl J Med , vol.365 , Issue.11 , pp. 993-1003
    • Chimowitz, M.I.1    Lynn, M.J.2    Derdeyn, C.P.3    Turan, T.N.4    Fiorella, D.5    Lane, B.F.6
  • 58
    • 65649145705 scopus 로고    scopus 로고
    • Effect of clopidogrel added to aspirin in patients with atrial fibrillation
    • 19336502 10.1056/NEJMoa0901301
    • Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, et al. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med. 2009;360(20):2066-78.
    • (2009) N Engl J Med. , vol.360 , Issue.20 , pp. 2066-2078
    • Connolly, S.J.1    Pogue, J.2    Hart, R.G.3    Hohnloser, S.H.4    Pfeffer, M.5    Chrolavicius, S.6
  • 59
    • 84871806093 scopus 로고    scopus 로고
    • Impact of platelet reactivity on long-term clinical outcomes and bleeding events in Japanese patients receiving antiplatelet therapy with aspirin
    • Yamane K, Ikeda T, Taniguchi R, Watanabe S, Kawato M, Kondo H, et al. Impact of platelet reactivity on long†term clinical outcomes and bleeding events in Japanese patients receiving antiplatelet therapy with aspirin. J Atheroscler Thromb. 2012;19(12):1142-53.
    • (2012) J Atheroscler Thromb , vol.19 , Issue.12 , pp. 1142-1153
    • Yamane, K.1    Ikeda, T.2    Taniguchi, R.3    Watanabe, S.4    Kawato, M.5    Kondo, H.6
  • 60
    • 84879099050 scopus 로고    scopus 로고
    • Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin
    • Siller-Matula JM, Delle-Karth G, Christ G, Neunteufl T, Maurer G, Huber K, et al. Dual non-responsiveness to antiplatelet treatment is a stronger predictor of cardiac adverse events than isolated non-responsiveness to clopidogrel or aspirin. Int J Cardiol. 2012.
    • (2012) Int J Cardiol
    • Siller-Matula, J.M.1    Delle-Karth, G.2    Christ, G.3    Neunteufl, T.4    Maurer, G.5    Huber, K.6
  • 61
    • 84865608720 scopus 로고    scopus 로고
    • Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack
    • Depta JP, Fowler J, Novak E, Katzan I, Bakdash S, Kottke-Marchant K, et al. Clinical outcomes using a platelet function-guided approach for secondary prevention in patients with ischemic stroke or transient ischemic attack. Stroke. 2012.
    • (2012) Stroke
    • Depta, J.P.1    Fowler, J.2    Novak, E.3    Katzan, I.4    Bakdash, S.5    Kottke-Marchant, K.6
  • 62
    • 56749182302 scopus 로고    scopus 로고
    • Aspirin "resistance" role of pre-existent platelet reactivity and correlation between tests
    • 18983514 10.1111/j.1538-7836.2008.03184.x 1:CAS:528:DC%2BD1MXhtFSkur8%3D
    • Frelinger AL, Li Y, Linden MD, Tarnow I, Barnard MR, Fox ML, et al. Aspirin "resistance" role of pre-existent platelet reactivity and correlation between tests. J Thromb Haemost. 2008;6:2035-44.
    • (2008) J Thromb Haemost. , vol.6 , pp. 2035-2044
    • Frelinger, A.L.1    Li, Y.2    Linden, M.D.3    Tarnow, I.4    Barnard, M.R.5    Fox, M.L.6
  • 63
    • 79955515500 scopus 로고    scopus 로고
    • Predictors of biochemical aspirin and clopidogrel resistance in patients with ischemic stroke
    • 20621513 10.1016/j.jstrokecerebrovasdis.2009.12.004
    • Fong J, Cheng-Ching E, Hussain MS, Katzan I, Gupta R. Predictors of biochemical aspirin and clopidogrel resistance in patients with ischemic stroke. J Stroke Cerebrovasc Dis. 2011;20(3):227-30.
    • (2011) J Stroke Cerebrovasc Dis. , vol.20 , Issue.3 , pp. 227-230
    • Fong, J.1    Cheng-Ching, E.2    Hussain, M.S.3    Katzan, I.4    Gupta, R.5
  • 64
    • 79953296443 scopus 로고    scopus 로고
    • Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention
    • 21273381 10.1681/ASN.2010020220 1:CAS:528:DC%2BC3MXlslKqu7o%3D
    • Htun P, Fateh-Moghadam S, Bischofs C, Banya W, Müller K, Bigalke B, et al. Low responsiveness to clopidogrel increases risk among CKD patients undergoing coronary intervention. J Am Soc Nephrol. 2011;22(4):627-33.
    • (2011) J Am Soc Nephrol. , vol.22 , Issue.4 , pp. 627-633
    • Htun, P.1    Fateh-Moghadam, S.2    Bischofs, C.3    Banya, W.4    Müller, K.5    Bigalke, B.6
  • 65
    • 57549099501 scopus 로고    scopus 로고
    • Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: A prospective, randomized study
    • 19463379 10.1016/j.jcin.2008.08.018
    • Cuisset T, Frere C, Quilici J, Morange PE, Mouret JP, Bali L, et al. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study. JACC Cardiovasc Interv. 2008;1:649-53.
    • (2008) JACC Cardiovasc Interv. , vol.1 , pp. 649-653
    • Cuisset, T.1    Frere, C.2    Quilici, J.3    Morange, P.E.4    Mouret, J.P.5    Bali, L.6
  • 66
    • 58149476444 scopus 로고    scopus 로고
    • Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis
    • 19101221 10.1016/j.amjcard.2008.08.048 1:CAS:528:DC%2BD1cXhsFajsr%2FP
    • Bonello L, Camoin-Jau L, Armero S, Com O, Arques S, Burignat-Bonello C, et al. Tailored clopidogrel loading dose according to platelet reactivity monitoring to prevent acute and subacute stent thrombosis. Am J Cardiol. 2009;103:5-10.
    • (2009) Am J Cardiol. , vol.103 , pp. 5-10
    • Bonello, L.1    Camoin-Jau, L.2    Armero, S.3    Com, O.4    Arques, S.5    Burignat-Bonello, C.6
  • 67
    • 84883281361 scopus 로고    scopus 로고
    • On behalf of the Tailored Antiplatelet Treatment Study Collaboration. Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: Systematic review and meta-analysis
    • Aradi D, Komócsi A, Price MJ, Cuisset T, Ari H, Hazarbasanov D, et al. on behalf of the Tailored Antiplatelet Treatment Study Collaboration. Efficacy and safety of intensified antiplatelet therapy on the basis of platelet reactivity testing in patients after percutaneous coronary intervention: systematic review and meta-analysis. Int J Cardiol. 2012.
    • (2012) Int J Cardiol
    • Aradi D, K.1
  • 68
    • 84864536401 scopus 로고    scopus 로고
    • Platelets in atherothrombosis - Diagnostic and prognostic value of platelet activation in patients with atherosclerotic diseases
    • Epub ahead of print
    • Bigalke B, Schuster A, Sopova K, Wurster T, Stellos K. Platelets in atherothrombosis - diagnostic and prognostic value of platelet activation in patients with atherosclerotic diseases. Curr Vasc Pharmacol. 2012;[Epub ahead of print].
    • (2012) Curr Vasc Pharmacol
    • Bigalke, B.1    Schuster, A.2    Sopova, K.3    Wurster, T.4    Stellos, K.5
  • 69
    • 84879607390 scopus 로고    scopus 로고
    • Concomitant use of clopidogrel and proton pump inhibitors: Impact on platelet function and clinical outcome- A systematic review
    • Epub ahead of print
    • Frocks J, Brouwer MA, van Oijen MG, Lanas A, Bhatt DL, Verheugt FW. Concomitant use of clopidogrel and proton pump inhibitors: impact on platelet function and clinical outcome- a systematic review. Heart. 2012 [Epub ahead of print].
    • (2012) Heart
    • Frocks, J.1    Brouwer, M.A.2    Van Oijen, M.G.3    Lanas, A.4    Bhatt, D.L.5    Verheugt, F.W.6
  • 71
    • 27644548513 scopus 로고    scopus 로고
    • Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: Randomised placebo-controlled trial
    • DOI 10.1016/S0140-6736(05)67660-X, PII S014067360567660X
    • Chen ZM, Jiang LX, Chen YP. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomized placebo-controlled trial. Lancet. 2005;366:1607-21. (Pubitemid 41552416)
    • (2005) Lancet , vol.366 , Issue.9497 , pp. 1607-1621
    • Chen, Z.1    Jiang, L.2
  • 72
    • 69249219296 scopus 로고    scopus 로고
    • Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy
    • 19706858 10.1001/jama.2009.1232 1:CAS:528:DC%2BD1MXhtVCnt7zL
    • Shuldiner AR, O'Connell JR, Bliden KP, Gandhi A, Ryan K, Horenstein RB, et al. Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA. 2009;302(8):849-57.
    • (2009) JAMA. , vol.302 , Issue.8 , pp. 849-857
    • Shuldiner, A.R.1    O'Connell, J.R.2    Bliden, K.P.3    Gandhi, A.4    Ryan, K.5    Horenstein, R.B.6
  • 73
    • 78049326068 scopus 로고    scopus 로고
    • Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: A meta-analysis
    • 20978260 10.1001/jama.2010.1543 1:CAS:528:DC%2BC3cXhtlGqurbO
    • Mega JL, Simon T, Collet JP, Anderson JL, Antman EM, Bliden K, et al. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA. 2010;304:1821-30.
    • (2010) JAMA. , vol.304 , pp. 1821-1830
    • Mega, J.L.1    Simon, T.2    Collet, J.P.3    Anderson, J.L.4    Antman, E.M.5    Bliden, K.6
  • 74
    • 84873086262 scopus 로고    scopus 로고
    • FDA Drug Safety Communication: Reduced effectiveness of Plavix (clopidogrel) in patients who are poor metabolizers of the drug
    • US Food and Drug Administration Food and Drug Administration (United States). March 12
    • US Food and Drug Administration. «FDA Drug Safety Communication: Reduced effectiveness of Plavix (clopidogrel) in patients who are poor metabolizers of the drug». Drug Safety and Availability. Food and Drug Administration (United States). March 12, 2010.
    • (2010) Drug Safety and Availability
  • 75
    • 84555195438 scopus 로고    scopus 로고
    • CyP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: A systematic review and meta-analysis
    • 10.1001/jama.2011.1880
    • Holmes MV, Perel P, Shah T, Hingorani AD, Casas JP. CyP2C19 genotype, clopidogrel metabolism, platelet function, and cardiovascular events: a systematic review and meta-analysis. JAMA. 2011;306(24):2709-14.
    • (2011) JAMA. , vol.306 , Issue.24 , pp. 2709-2714
    • Holmes, M.V.1    Perel, P.2    Shah, T.3    Hingorani, A.D.4    Casas, J.P.5
  • 78
    • 79551530662 scopus 로고    scopus 로고
    • Safety of clopidogrel in older patients: A nonrandomized, parallel-group, controlled, 2-center study
    • 21275437 10.2165/11586380-000000000-00000 1:CAS:528:DC%2BC3MXjsFOmtbc%3D
    • Cay S, Cagirci G, Aydogdu S, Balbay Y, Sen N, Maden O, et al. Safety of clopidogrel in older patients: a nonrandomized, parallel-group, controlled, 2-center study. Drugs Aging. 2011;28(2):119-29.
    • (2011) Drugs Aging. , vol.28 , Issue.2 , pp. 119-129
    • Cay, S.1    Cagirci, G.2    Aydogdu, S.3    Balbay, Y.4    Sen, N.5    Maden, O.6
  • 79
    • 80455149677 scopus 로고    scopus 로고
    • Diurnal variation in platelet inhibition by clopidogrel
    • 10.3109/09537104.2011.582900 21627410 10.3109/09537104.2011.582900 1:CAS:528:DC%2BC3MXhsVWmu7zI [Epub 2011 May 31]
    • Kozinski M, Bielis L, Wisniewska-Szmyt J, Boinska J, Stolarek W, Marciniak A, et al. Diurnal variation in platelet inhibition by clopidogrel. Platelets. 2011;22(8):579-87. doi: 10.3109/09537104.2011.582900 [Epub 2011 May 31].
    • (2011) Platelets. , vol.22 , Issue.8 , pp. 579-587
    • Kozinski, M.1    Bielis, L.2    Wisniewska-Szmyt, J.3    Boinska, J.4    Stolarek, W.5    Marciniak, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.